Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Product comparison

1 evidence topic · 1 source

ConfIdeS: randomized comparison of kidney function at 12 months

Outcome	Imlifidase arm	Control arm
Mean eGFR, mL/min/1.73 m²	“51.5”	“19.3”